Stomach-protecting drugs, especially so-called proton pump inhibitors or PPIs, correlate with subsequent prescriptions for anti-allergy medication, an Austrian study shows. Using quantitative prescribing data from Austria, the study, conducted by MedUni Vienna in collaboration with the Austrian Social Insurance Institutions, validates the finding of previous epidemiological and experimental studies that stomach-protecting drugs can intensify or… Read more

Medical consensus once supported daily use of low dose aspirin to prevent heart attack and stroke in people at increased risk for cardiovascular disease (CVD). But in 2018, three major clinical trials cast doubt on that conventional wisdom, finding few benefits and consistent bleeding risks associated with daily aspirin use. Taken together, the findings led… Read more

High levels of URI protein protect mice from radiation-induced intestinal damage, whereas low or no detectable levels of the protein can lead to gastrointestinal syndrome and death, new research from Spain shows. Radiotherapy is among the most effective ways to kill cancer cells and shrink tumors. Around 50 percent of patients with tumors located in… Read more

A subtype of Blastocystis, a common kind of gut bacteria, can kill good bacteria in the body and could potentially even lead to colon cancer, reports a study from the National University of Singapore. Since most of the microbes in our gut are bacteria, they tend to hog much of the microbiome research limelight. But… Read more

An important mechanism that controls immune reactions against microorganisms in the intestine has been detailed by Universitätsmedizin Berlin researchers. The findings of the international study may contribute to the development of new therapies for chronic inflammatory bowel disease. “We have identified a molecule, c-Maf, which is critical for the development and function of specific regulatory… Read more